Enzyme-replacement Therapy in Mucopolysaccharidoses \nwith a Specific Focus on MPS VI
Year: 2013
Type: dissertation
Abstract: Before the discovery of the lysosome, already three out of the seven currently known \nmucopolysaccharidoses (MPSs) were described in medical literature. In 1917, Hunter \nsyndrome was the first to be described in two brothers (“they are as alike as two peas”) \nby Charles Hunter. Gertrud Hurler published her two case reports about MPS I in 1919, \nand MPS IV was outlined in 1929 by the Uruguayan dr. Morquio. All described young \nchildren with or without mental impairment, with profound bone abnormalities. \nIn 1955, the Belgian scientist Christian de Duve discovered a new intra-cellular organelle \nthat he named the lysosome. Eventually, this brought light to more than 50 inherited diseases \nall concerning a defect in the lysosomal system. The group of mucopolysaccharidoses \nbelonged to these lysosomal disorders and all types proved to be characterized by the \ndeficiency of a lysosomal enzyme. New types of MPSs were discovered since then. \nIn 1963 two French physicians described a new form of dysostosis mupltiplex, MPS VI, \nand the syndrome was named after them: Maroteaux-Lamy’s syndrome 4. In the same \nyear dr. Sanfilippo described for the first time a MPS III patient with mental impairment \nand excretion of heparan sulphate. Later, Sanfillippo disease was subdivided in type A, B, \nC, and D because between 1972 and 1980 different enzyme deficiencies were discovered \nin each of the four subtypes. Finally, in 1973, MPS VII was described by the American \ndr. Sly . MPS V and MPS VIII, first thought to be novel diseases, later turned out to be \nalready known types of MPS and are not separate entities anymore. In 1996 Natowicz et al \nreported the first patient with MPS IX . Till now, only one other family has been reported \nwith this disease.
Author: Brands, M.M.M.G. (Marion)
Institution: Erasmus University Rotterdam
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: European Commission, ZonMw
OpenAlex ID: W6981559316
